| Health care resource utilization and exacerbation rates in patients with COPD stratified by disease severity in a commercially insured population AE Wallace, S Kaila, V Bayer, A Shaikh, MU Shinde, VJ Willey, MB Napier, ... Journal of managed care & specialty pharmacy 25 (2), 205-217, 2019 | 52 | 2019 |
| Effect of compliance with GOLD treatment recommendations on COPD health care resource utilization, cost, and exacerbations among patients with COPD on maintenance therapy SR Palli, S Zhou, A Shaikh, VJ Willey Journal of Managed Care & Specialty Pharmacy 27 (5), 625-637, 2021 | 19 | 2021 |
| Relative efficacy and safety of inhaled corticosteroids in patients with asthma: systematic review and network meta-analysis B Chipps, B Taylor, V Bayer, A Shaikh, G Mosnaim, J Trevor, S Rogers, ... Annals of Allergy, Asthma & Immunology 125 (2), 163-170. e3, 2020 | 19 | 2020 |
| Initiation of triple therapy maintenance treatment among patients with COPD Y Li, J Lim, S Stemkowski, S Kaila, A Renda, A Shaikh Am J Manag Care 26 (4), e106-e112, 2020 | 12 | 2020 |
| Low peak inspiratory flow rates are common among COPD inpatients and are associated with increased healthcare resource utilization: a retrospective cohort study B Clark, BJ Wells, AK Saha, J Franchino-Elder, A Shaikh, BMK Donato, ... International Journal of Chronic Obstructive Pulmonary Disease, 1483-1494, 2022 | 11 | 2022 |
| Add-on tiotropium versus step-up inhaled corticosteroid plus long-acting beta-2‐agonist in real-world patients with asthma B Chipps, G Mosnaim, SK Mathur, A Shaikh, S Khoury, G Gopalan, ... Allergy and asthma proceedings 41 (4), 248-255, 2020 | 11 | 2020 |
| Design, rationale, and baseline demographics of SEARCH I: a prospective cluster-randomized study F Albers, A Shaikh, A Iqbal International Journal of Chronic Obstructive Pulmonary Disease, 437-445, 2012 | 11 | 2012 |
| High prevalence of suboptimal peak inspiratory flow in hospitalized patients with COPD: a real-world study DA Mahler, S Demirel, R Hollander, G Gopalan, A Shaikh, CD Mahle, ... Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 9 (3 …, 2022 | 7 | 2022 |
| TRONARTO: a randomized, placebo-controlled study of tiotropium/olodaterol delivered via soft mist inhaler in COPD patients stratified by peak inspiratory flow DA Mahler, A Ludwig-Sengpiel, GT Ferguson, A de la Hoz, J Ritz, ... International Journal of Chronic Obstructive Pulmonary Disease, 2455-2465, 2021 | 6 | 2021 |
| Effect of inhaled corticosteroid withdrawal on chronic obstructive pulmonary disease exacerbations in patients taking triple therapy at baseline GT Ferguson, A Shaikh, K Tetzlaff, A Mueller, H Magnussen, H Watz International journal of chronic obstructive pulmonary disease, 2879-2888, 2020 | 6 | 2020 |
| Effect of tiotropium on spontaneous expiratory flow–volume curves during exercise in GOLD 1-2 COPD J Porszasz, N Carraro, R Cao, A Gore, S Ma, T Jiang, F Maltais, ... Respiratory physiology & neurobiology 251, 8-15, 2018 | 6 | 2018 |
| COPD population in US primary care: data from the optimum patient care DARTNet research database and the advancing the patient experience in COPD registry WD Pace, E Brandt, VA Carter, KL Chang, CL Edwards, A Evans, C Fox, ... The Annals of Family Medicine 20 (4), 319-327, 2022 | 4 | 2022 |
| Advancing the Patient Experience (APEX) in COPD registry: study design and strengths BP Yawn, A Kaplan, WD Pace, JWH Kocks, L Bulathsinhala, VA Carter, ... The Journal of the American Board of Family Medicine 34 (1), 22-31, 2021 | 4 | 2021 |
| Development of the Advancing the Patient Experience in COPD registry: a modified delphi study CL Edwards, AG Kaplan, BP Yawn, JWH Kocks, L Bulathsinhala, ... Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation 8 (1 …, 2021 | 4 | 2021 |
| Clinical implications of peak inspiratory flow in COPD: post hoc analyses of the TRONARTO study DA Mahler, H Watz, R Emerson-Stadler, J Ritz, A Gardev, A Shaikh, ... International Journal of Chronic Obstructive Pulmonary Disease, 1729-1740, 2023 | 3 | 2023 |
| Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease LC Myers, R Murray, B Donato, VX Liu, P Kipnis, A Shaikh, ... Respiratory Medicine 206, 107064, 2023 | 3 | 2023 |
| Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate … S Sethi, SR Palli, LGS Bengtson, EK Buysman, B Clark, A Sargent, ... Journal of Managed Care & Specialty Pharmacy 29 (7), 791-806, 2023 | 2 | 2023 |
| Effective Outcome of HBOT as an Adjuvant Therapy in Patients Diagnosed with COVID-19 in a Tertiary Care Hospital–A Preliminary Study T Palaniappan, A Shaikh, N Kirthika The Journal of Critical Care Medicine 8 (3), 176-181, 2022 | 2 | 2022 |
| Developing a claims’-based algorithm to identify US patients with COPD S Palli, S Zhou, A Shaikh, V Willey European Respiratory Journal 54 (suppl 63), 2019 | 2 | 2019 |
| Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium … S Sethi, B Clark, LGS Bengtson, EK Buysman, S Palli, A Sargent, ... International Journal of Chronic Obstructive Pulmonary Disease, 625-641, 2023 | 1 | 2023 |
